Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase.

Sasaki, T; Gannam, Z.; Kudalkar, S.; Frey, K.; Lee, W.; Spasov, K.; Jorgensen, W.; Anderson, K.

doi:10.1016/j.bmcl.2019.06.047

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase.

Journal Article · 01 January 2021 · Bioorganic and Medicinal Chemistry Letters

DOI:https://doi.org/10.1016/j.bmcl.2019.06.047· OSTI ID:1689953

Sasaki, T; Gannam, Z.; Kudalkar, S.; Frey, K.; Lee, W.; Spasov, K.; Jorgensen, W.; Anderson, K.

Research Organization:: Brookhaven National Lab. (BNL), Upton, NY (United States)

Sponsoring Organization:: ~OTHER

DOE Contract Number:: SC0012704

OSTI ID:: 1689953

Report Number(s):: BNL-220282-2020-JACI

Journal Information:: Bioorganic and Medicinal Chemistry Letters, Vol. 29, Issue 16

Country of Publication:: United States

Language:: English

References (31)

Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets Adamson, C. S.; Freed, E. O. Molecular Interventions, Vol. 9, Issue 2 https://doi.org/10.1124/mi.9.2.5	journal	April 2009
Novel approaches to inhibiting HIV-1 replication Adamson, Catherine S.; Freed, Eric O. Antiviral Research, Vol. 85, Issue 1 https://doi.org/10.1016/j.antiviral.2009.09.009	journal	January 2010
Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase Tantillo, Chris; Ding, Jianping; Jacobo-Molina, Alfredo Journal of Molecular Biology, Vol. 243, Issue 3 https://doi.org/10.1006/jmbi.1994.1665	journal	October 1994
Natural history of HIV infection in the_era of combination antiretroviral therapy Moore, Richard D.; Chaisson, Richard E. AIDS, Vol. 13, Issue 14 https://doi.org/10.1097/00002030-199910010-00017	journal	January 1999
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future De Clercq, Erik Chemistry & Biodiversity, Vol. 1, Issue 1 https://doi.org/10.1002/cbdv.200490012	journal	January 2004
Viral dynamics in human immunodeficiency virus type 1 infection Wei, Xiping; Ghosh, Sajal K.; Taylor, Maria E. Nature, Vol. 373, Issue 6510 https://doi.org/10.1038/373117a0	journal	January 1995
Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy Jourdain, Gonzague; Ngo-Giang-Huong, Nicole; Le Coeur, Sophie New England Journal of Medicine, Vol. 351, Issue 3 https://doi.org/10.1056/NEJMoa041305	journal	July 2004
Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy Bacheler, Lee T.; Anton, Elizabeth D.; Kudish, Phil Antimicrobial Agents and Chemotherapy, Vol. 44, Issue 9 https://doi.org/10.1128/AAC.44.9.2475-2484.2000	journal	September 2000
In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) Reynolds, Chevonne; de Koning, Charles B.; Pelly, Stephen C. Chemical Society Reviews, Vol. 41, Issue 13 https://doi.org/10.1039/c2cs35058k	journal	January 2012
TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Andries, Koen; Azijn, Hilde; Thielemans, Theo Antimicrobial Agents and Chemotherapy, Vol. 48, Issue 12 https://doi.org/10.1128/AAC.48.12.4680-4686.2004	journal	December 2004
In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1 E )-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine) Janssen, Paul A. J.; Lewi, Paul J.; Arnold, Eddy Journal of Medicinal Chemistry, Vol. 48, Issue 6 https://doi.org/10.1021/jm040840e	journal	March 2005
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling Bowes, Joanne; Brown, Andrew J.; Hamon, Jacques Nature Reviews Drug Discovery, Vol. 11, Issue 12 https://doi.org/10.1038/nrd3845	journal	November 2012
Computationally-Guided Optimization of a Docking Hit to Yield Catechol Diethers as Potent Anti-HIV Agents Bollini, Mariela; Domaoal, Robert A.; Thakur, Vinay V. Journal of Medicinal Chemistry, Vol. 54, Issue 24 https://doi.org/10.1021/jm201134m	journal	December 2011
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection Kudalkar, Shalley N.; Beloor, Jagadish; Quijano, Elias Proceedings of the National Academy of Sciences, Vol. 115, Issue 4 https://doi.org/10.1073/pnas.1717932115	journal	December 2017
Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography Chan, Albert H.; Lee, Won-Gil; Spasov, Krasimir A. Proceedings of the National Academy of Sciences, Vol. 114, Issue 36 https://doi.org/10.1073/pnas.1711463114	journal	August 2017
Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase Frey, Kathleen M.; Gray, William T.; Spasov, Krasimir A. Chemical Biology & Drug Design, Vol. 83, Issue 5 https://doi.org/10.1111/cbdd.12266	journal	March 2014
Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group Lee, Won-Gil; Gallardo-Macias, Ricardo; Frey, Kathleen M. Journal of the American Chemical Society, Vol. 135, Issue 44 https://doi.org/10.1021/ja408917n	journal	October 2013
Compensation by the E138K Mutation in HIV-1 Reverse Transcriptase for Deficits in Viral Replication Capacity and Enzyme Processivity Associated with the M184I/V Mutations Xu, H. -T.; Asahchop, E. L.; Oliveira, M. Journal of Virology, Vol. 85, Issue 21 https://doi.org/10.1128/JVI.05584-11	journal	August 2011
Characterization of PicoGreen Reagent and Development of a Fluorescence-Based Solution Assay for Double-Stranded DNA Quantitation Singer, Victoria L.; Jones, Laurie J.; Yue, Stephen T. Analytical Biochemistry, Vol. 249, Issue 2 https://doi.org/10.1006/abio.1997.2177	journal	July 1997
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later Pannecouque, Christophe; Daelemans, Dirk; De Clercq, Erik Nature Protocols, Vol. 3, Issue 3 https://doi.org/10.1038/nprot.2007.517	journal	February 2008
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations Das, K.; Bauman, J. D.; Clark, A. D. Proceedings of the National Academy of Sciences, Vol. 105, Issue 5 https://doi.org/10.1073/pnas.0711209105	journal	January 2008
Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility Bollini, Mariela; Frey, Kathleen M.; Cisneros, José A. Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 18 https://doi.org/10.1016/j.bmcl.2013.06.093	journal	September 2013
Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design Frey, Kathleen M.; Bollini, Mariela; Mislak, Andrea C. Journal of the American Chemical Society, Vol. 134, Issue 48 https://doi.org/10.1021/ja3092642	journal	November 2012
Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses Kertesz, Denis J.; Brotherton-Pleiss, Christine; Yang, Minmin Bioorganic & Medicinal Chemistry Letters, Vol. 20, Issue 14 https://doi.org/10.1016/j.bmcl.2010.05.040	journal	July 2010
Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant: The HIV-1 RT K103N mutant and inhibitor efficacy Lindberg, Jimmy; Sigurðsson, Snaevar; Löwgren, Seved European Journal of Biochemistry, Vol. 269, Issue 6 https://doi.org/10.1046/j.1432-1327.2002.02811.x	journal	March 2002
Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants Frey, Kathleen M.; Puleo, David E.; Spasov, Krasimir A. Journal of Medicinal Chemistry, Vol. 58, Issue 6 https://doi.org/10.1021/jm501908a	journal	February 2015
Physicochemical Properties of the Amorphous Drug, Cast Films, and Spray Dried Powders to Predict Formulation Probability of Success for Solid Dispersions: Etravirine Weuts, Ilse; Van Dycke, Frederic; Voorspoels, Jody Journal of Pharmaceutical Sciences, Vol. 100, Issue 1 https://doi.org/10.1002/jps.22242	journal	January 2011
Structural Basis for the Improved Drug Resistance Profile of New Generation Benzophenone Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors Ren, Jingshan; Chamberlain, Philip P.; Stamp, Anna Journal of Medicinal Chemistry, Vol. 51, Issue 16 https://doi.org/10.1021/jm8004493	journal	July 2008
In Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Lai, Ming-Tain; Feng, Meizhen; Falgueyret, Jean-Pierre Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 3 https://doi.org/10.1128/AAC.02403-13	journal	December 2013
Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses Côté, Bernard; Burch, Jason D.; Asante-Appiah, Ernest Bioorganic & Medicinal Chemistry Letters, Vol. 24, Issue 3 https://doi.org/10.1016/j.bmcl.2013.12.070	journal	February 2014
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection Kudalkar, Shalley N.; Beloor, Jagadish; Chan, Albert H. Molecular Pharmacology, Vol. 91, Issue 4 https://doi.org/10.1124/mol.116.107755	journal	February 2017

Similar Records

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase

Journal Article · 2019 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1698246

Sasaki, Tomoaki; Gannam, Zira T. K.; Kudalkar, Shalley N.; +5 more

Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase

Journal Article · 2014 · Chemical Biology and Drug Design · OSTI ID:1162949

Frey, K.; Gray, W.; Spasov, K.; +4 more

Structural investigation of 2-naphthyl phenyl ether inhibitors bound to WT and Y181C reverse transcriptase highlights key features of the NNRTI binding site

Journal Article · 2022 · Protein Science · OSTI ID:1690145

Duong, V; Ippolito, J.; Chan, A.; +4 more

Related Subjects

99 GENERAL AND MISCELLANEOUS

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase.

Citation Formats

References (31)

Similar Records

Related Subjects